S. Della-Fiorentina

发表

Risk of emergency hospitalisation and survival outcomes following adjuvant chemotherapy for early breast cancer in New South Wales, Australia.

D. Currow, J. Beith, F. Boyle, 2019, European journal of cancer care.

Observation versus late reintroduction of letrozole as adjuvant endocrine therapy for hormone receptor-positive breast cancer (ANZ0501 LATER): an open-label randomised, controlled trial.

J. Cuzick, J. Forbes, V. Gebski, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Relative dose intensity in early stage breast cancer chemotherapy: A retrospective analysis of incidence, risk factors and outcomes at a south‐west Sydney cancer clinic

S. Della-Fiorentina, J. Sandy, 2013, Asia-Pacific journal of clinical oncology.

Use of palliative chemotherapy in patients aged 80 years and over with incurable cancer: experience at three Sydney cancer centres

B. Kiely, P. Beale, A. Pokorny, 2017, Internal medicine journal.

Factors delaying chemotherapy for breast cancer in four urban and rural oncology units

M. Chatfield, J. Beith, P. Grimison, 2013, ANZ journal of surgery.

Assessing outcomes of cancer care: lessons to be learned from a retrospective review of the management of small cell lung cancer at the Cancer Therapy Centre, Liverpool Hospital, January 1996-July 2000.

P. Ellis, G. Delaney, E. Moylan, 2004, Australasian radiology.

Primary peritoneal carcinoma: a treatable subset of patients with adenocarcinoma of unknown primary.

P. Harnett, A. Crandon, S. Della-Fiorentina, 1996, The Australian and New Zealand journal of surgery.

A short outpatient hydration schedule for cisplatin administration.

B. Forouzesh, E. Moylan, S. Della-Fiorentina, 2009, The Gulf journal of oncology.

Older adults' preferred and perceived roles in decision-making about palliative chemotherapy, decision priorities and information preferences.

B. Kiely, V. Naganathan, C. Steer, 2020, Journal of geriatric oncology.

Doctor‐to‐doctor communication of prognosis in metastatic cancer: a review of letters from medical oncologists to referring doctors

B. Kiely, M. Stockler, P. Beale, 2015, Internal medicine journal.

Development and Feasibility Testing of PROMPT-Care, an eHealth System for Collection and Use of Patient-Reported Outcome Measures for Personalized Treatment and Care: A Study Protocol

M. Carolan, H. Dhillon, A. Girgis, 2016, JMIR research protocols.

The impact and indications for Oncotype DX on adjuvant treatment recommendations when third‐party funding is unavailable

B. Kiely, G. Mann, Y. Antill, 2018, Asia-Pacific journal of clinical oncology.

A PILOT STUDY OF PREOPERATIVE AND POSTOPERATIVE CHEMOTHERAPY IN PATIENTS WITH OPERABLE GASTRIC CANCER: AUSTRALASIAN GASTROINTESTINAL TRIALS GROUP STUDY 9601

V. Gebski, D. Goldstein, H. Dhillon, 2007, ANZ journal of surgery.

The efficacy of oral ondansetron and dexamethasone for the prevention of acute chemotherapy-induced nausea and vomiting associated with moderately emetogenic chemotherapy - a retrospective audit.

S. Della-Fiorentina, W. L. Ng, 2010, European journal of cancer care.

Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting (CINV): a randomised, placebo-controlled, phase 2 crossover trial.

M. Stockler, C. Gedye, J. Simes, 2020, Annals of oncology : official journal of the European Society for Medical Oncology.

Web-Based Patient-Reported Outcome Measures for Personalized Treatment and Care (PROMPT-Care): Multicenter Pragmatic Nonrandomized Trial

M. Carolan, A. Girgis, J. Descallar, 2020, Journal of medical Internet research.

Cancer Care Team’s Management of Clinical Alerts Generated by Electronically Collected Patient Reported Outcomes: We Could Do Better

A. Bamgboje-Ayodele, A. Girgis, I. Durcinoska, 2023, International journal of environmental research and public health.

Study protocol for a controlled trial of an eHealth system utilising patient reported outcome measures for personalised treatment and care: PROMPT-Care 2.0

A. Girgis, J. Descallar, Janelle V Levesque, 2018, BMC Cancer.

Survival times of women with metastatic breast cancer starting first‐line chemotherapy in routine clinical practice versus contemporary randomised trials

B. Kiely, M. Stockler, L. Chantrill, 2013, Internal medicine journal.

The prompt-care project: eHealth system utilising patient reported outcomes to inform personalised cancer treatment and care

M. Carolan, A. Girgis, G. Delaney, 2014 .

Web-Based Patient-Reported Outcome Measures for Personalized Treatment and Care (PROMPT-Care): Multicenter Pragmatic Nonrandomized Trial (Preprint)

M. Carolan, A. Girgis, J. Descallar, 2020 .

Talactoferrin alfa versus placebo in patients with refractory advanced non-small-cell lung cancer (FORTIS-M trial).

J. S. Lee, D. R. Berry, G. Giaccone, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

The prompt-care project: eHealth system utilising patient reported outcomes to inform personalised cancer treatment and care

A. Girgis, Ashley E Maher, S. Della-Fiorentina, 2014 .

Final analysis of a randomized comparison of letrozole (Let) vs observation (Obs) as late reintroduction of adjuvant endocrine therapy (AET) for postmenopausal women with hormone receptor positive (HR+) breast cancer (BC) after completion of prior AET: ANZBCTG 0501 (LATER).

J. Forbes, V. Gebski, F. Boyle, 2015 .